Search Results

0 results for ''Robbins Geller Rudman & Dowd LLP''

You can use to get even better search results
May 22, 2017 |

Class Action Against Fishing Operator Moves to SDNY

An investor class action case transferred into the Southern District Friday, alleging a fishing operation that produces food and supplement ingredients misled investors over multiple federal investigations over environmental law violations and whistleblower intimidation.
5 minute read
May 15, 2017 |

These Two Firms Are Driving a Surge in Health Sector Securities Class Actions

Securities lawsuits have become a major headache for life sciences companies, according to recent reports. And two plaintiffs' firms, Pomerantz and The Rosen Law Firm, are leading the charge.
16 minute read
May 09, 2017 | Insurance Coverage Law Center

Friedman v. AARP, Inc.

Click Here for FC&S Legal Expert Analysis  Friedmanv.AARP, Inc.United States Court of Appeals for the Ninth CircuitOctober 19, 2016, Argued…
24 minute read
May 08, 2017 |

Firms Vie for Leadership Post in Tesla Derivative Litigation

Plaintiffs' attorneys are setting up for a battle in Delaware federal court over lead counsel status in derivative litigation challenging Tesla Inc.'s $2.6 billion bid to acquire an allegedly failing solar energy system installer SolarCity Corp.
16 minute read
May 08, 2017 | Insurance Coverage Law Center

9th Circuit Reinstates Suit Asserting That AARP’s Medigap Policy Violated California Insurance Law

The U.S. Court of Appeals for the Ninth Circuit has reinstated a complaint alleging that AARP, through its arrangement with UnitedHealthcare Insurance…
6 minute read
City of Dearborn Heights Act 345 Police and Fire Retirement System v. Align Technology, Inc.
Publication Date: 2017-05-05
Practice Area:
Industry: Technology Media and Telecom
Court: 9th Cir.
Judge: Beth Labson Freeman, District Judge, Presiding Before: ANDREW J. KLEINFELD and MILAN D. SMITH, JR., Circuit Judges, and JOHN A. KRONSTADT,*District Judge.
Attorneys:
For plaintiff: Amanda M. Frame (argued), Christopher M. Wood, Shawn A. Williams, Andrew S. Love, and Susan K. Alexander, Robbins Geller Rudman & Dowd LLP, San Francisco, California; Darren J. Robbins, Robbins Geller Rudman & Dowd LLP, San Diego, California; for Plaintiff-Appellant.
For defendant: Caz Hashemi (argued), Nicholas R. Miller, Kelley M. Kinney, and Douglas J. Clark, Wilson Sonsini Goodrich & Rosati, Palo Alto, California, for Defendants-Appellees.
Case number: No. 14-16814

Omnicare standards for pleading falsity of opinion statements applied to shareholder claims under §10(b) and Rule 10b-5 (M.D. Smith, J.)

Friedman v. AARP, Inc.
Publication Date: 2017-05-03
Practice Area:
Industry: Non–Profit
Court: 9th Cir.
Judge: Dean D. Pregerson, District Judge, Presiding Before: Richard C. Tallman, Barrington D. Parker, Jr.* and Morgan Christen, Circuit Judges.
Attorneys:
For plaintiff: Andrew S. Love (argued) and Susan K. Alexander, Robbins Geller Rudman & Dowd LLP, San Francisco, California; Kevin K. Green, Frank J. Janecek, Jr., and Christopher Collins, Robbins Geller Rudman & Dowd LLP, San Diego, California; Stuart A. Davidson, Mark J. Dearman, and Christopher C. Martins, Robbins Geller Rudman & Dowd LLP, Boca Raton, Florida; Sean K. Collins, Boston, Massachusetts; Michael F. Ghozland, Ghozland Law Firm, Los Angeles, California; for Plaintiff-Appellant.
For defendant: Brian D. Boyle (argued) and Meaghan VerGow, O'Melveny & Myers LLP, Washington, D.C.; Christopher B. Craig, Los Angeles, California; for Defendants-Appellees UnitedHealth Group, Inc. and United HealthCare Insurance Company.
Case number: No. 14-56765

Plaintiff adequately stated claim based on AARP's alleged unlicensed sale of Medigap insurance in California (Parker, J.)

April 26, 2017 |

Mylan Faces Suits by Sanofi, Consumers Over EpiPen Pricing

Already under scrutiny from lawmakers over pricing of its EpiPen epinephrine injector, Mylan faces new lawsuits from consumers and a competitor in New Jersey federal courts accusing it of taking anti-competitive actions to protect its product's market share.
13 minute read
April 26, 2017 | New Jersey Law Journal

Mylan Faces Suits by Sanofi, Consumers Over EpiPen Pricing

Already under scrutiny from lawmakers over pricing of its EpiPen epinephrine injector, Mylan faces new lawsuits from consumers and a competitor in New Jersey federal courts accusing it of taking anti-competitive actions to protect its product's market share.
13 minute read

TRENDING STORIES

    Resources

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now

    • Practical Guidance Journal: Protecting Work Product in a Generative AI World

      Brought to you by LexisNexis®

      Download Now